Saroja Pharma Industries India Limited

NSEI:SAROJA Stock Report

Market Cap: ₹213.1m

Saroja Pharma Industries India Valuation

Is SAROJA undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of SAROJA when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate SAROJA's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate SAROJA's fair value for valuation analysis.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for SAROJA?

Key metric: As SAROJA is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for SAROJA. This is calculated by dividing SAROJA's market cap by their current earnings.
What is SAROJA's PE Ratio?
PE Ratio29.9x
Earnings₹7.12m
Market Cap₹213.09m

Price to Earnings Ratio vs Peers

How does SAROJA's PE Ratio compare to its peers?

The above table shows the PE ratio for SAROJA vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average39.6x
530697 Zenlabs Ethica
73.3xn/a₹264.0m
543594 Dipna Pharmachem
18.1xn/a₹196.4m
538874 Nexus Surgical and Medicare
34xn/a₹136.0m
542934 Chandra Bhagat Pharma
32.9xn/a₹520.6m
SAROJA Saroja Pharma Industries India
29.9xn/a₹213.1m

Price-To-Earnings vs Peers: SAROJA is good value based on its Price-To-Earnings Ratio (29.9x) compared to the peer average (39.6x).


Price to Earnings Ratio vs Industry

How does SAROJA's PE Ratio compare vs other companies in the IN Healthcare Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
523696 Fortis Malar Hospitals
2.5xn/aUS$14.05m
No more companies available in this PE range
SAROJA 29.9xIndustry Avg. 46.9xNo. of Companies7PE020406080100+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: SAROJA is good value based on its Price-To-Earnings Ratio (29.9x) compared to the Indian Healthcare industry average (46.9x).


Price to Earnings Ratio vs Fair Ratio

What is SAROJA's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

SAROJA PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio29.9x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate SAROJA's Price-To-Earnings Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies